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research organization, or the research sponsor nor may they 
be related to any individual who is part of these organizations; 
and members may not have conflicts of interest in regard to 
the projects that come under their review. 
 
Protected Health Information (PHI): This is  
individually identifiable health information that is transmitted 
by electronic media, maintained in electronic media, or shared 
in any other form or medium. The 18 types of Protected 
Health Information (PHI) are: names, geographic subdivisions 
smaller than a state (street address, city, county, precinct, zip 
code (allowing the retention of the first three digits of zip 
codes if the zip code area contains more than 20,000 people), 
all date elements except the year (for example, admission 
date, birth date, or discharge date), all ages over 89 (allowing 
for ages to be collapsed into one category labeled “90 and 
over”), telephone numbers, fax numbers, e-mail addresses, 
Social Security numbers, medical record numbers, health plan 
numbers, account numbers, certificate or license numbers, 
vehicle identification/serial numbers/license plate numbers, 
device identification/serial numbers, URLs, internet protocol 
(IP) addresses, biometric identifiers (for example, fingerprints, 
voiceprints, and dental x-rays), full-face photographs and 
comparable images, and any other unique identifying number, 
characteristic, or code. 
 
Separate Unit: A distinct entity housed within a larger 
organization. Sometimes a hospital is considered a separate 
entity within the larger university. In this case the hospital  
employees would be considered “covered entities” but the  
university researchers would not.  
 
Waiver of Authorization: Written authorization from 
the Institutional Review Board (IRB) or Privacy Board that fully 
or partially waives the HIPAA requirement for individual  
participant authorization. Before a waiver is granted the IRB or 
Privacy Board must be satisfied that the participants’ privacy 
and welfare will not be adversely affected by the researcher’s 
use of protected health information. 
 
ÚÚÚ 
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Institutional Review Board (IRB): An IRB is a board 
or other group designated by an institution to review the legal 
and ethical aspects of research involving humans as subjects. 
The board is comprised of individuals from the organization, as 
well as outside representatives. Board members should have 
research expertise and an understanding of the issues  
involved in human subjects protections. IRBs have authority to 
approve of, disapprove of, or require modifications to all  
research activities covered by the federal human subjects rule 
(45 CFR 46). Hospitals, academic medical centers, govern-
ment units, universities, and others engaged in research  
activities involving human subjects have their own designated 
IRBs or submit their protocols to an outside IRB for review. 
 
Limited Data Set: The following identifiers must be  
removed from the health information if the data are to qualify 
as part of a limited data set: names; postal address  
information, other than city, state, and zip code; telephone 
numbers; fax numbers; electronic mail addresses; social  
security numbers; medical record numbers; health beneficiary 
numbers; account numbers; certification/license numbers;  
vehicle identifiers and serial numbers, including license plate 
numbers; device identifiers and serial numbers; web universal 
resource locators (URLs); internet protocol (IP) address  
numbers; biometric identifiers, including fingerprints and  
voiceprints; and full-face photographic images and any  
comparable images. The limited data set can be used for  
purposes of research, public health, or health care operations 
without the researcher obtaining an individual’s authorization 
for its use or disclosure as long as a data use agreement is in 
place. 
 
Privacy Board: A privacy board is an alternative to an 
Institutional Review Board developed for the purpose of  
reviewing requests for alteration or waivers of research  
authorizations under the HIPAA statute. Privacy boards and 
the rules for their establishment were authorized by the HIPAA 
Privacy Rule. Members must have varying backgrounds and 
professional competencies; each board must have at least one  
member who is not affiliated with the covered entity, the  
15 
Data Use Agreement: The means by which covered 
entities obtain satisfactory assurance that the recipient of the 
limited data set will use or disclose PHI in the data set only for 
specified purposes. A written data use agreement meeting the 
Privacy Rule’s (HIPAA) requirements must be in place  
between the covered entity and the limited data set recipient. 
 
De-Identified Data: De-identified data are those with 
the following personally identifiable items removed: names, 
geographic subdivisions smaller than a state (street address, 
city, county, precinct, zip code (allowing the retention of the 
first three digits of zip codes if the zip code area contains 
more than 20,000 people), all date elements except the year 
(for example, admission date, birth date, or discharge date), 
all ages over 89 (allowing for ages to be collapsed into one 
category labeled “90 and over”), telephone numbers, fax  
numbers, e-mail addresses, Social Security numbers, medical 
record numbers, health plan numbers, account numbers,  
certificate or license numbers, vehicle identification/serial 
numbers/license plate numbers, device identification/serial 
numbers, URLs, internet protocol addresses, biometric  
identifiers (for example, fingerprints, voiceprints, and dental  
x-rays), full-face photographs and comparable images, and 
any other unique identifying number, characteristic, or code. 
 
Health Insurance Portability and Accountability Act 
of 1996 (HIPAA): A Federal law that allows persons to qualify 
immediately for comparable health insurance coverage when 
they change their employment relationships. Title II, of HIPAA 
gives HHS the authority to mandate the use of standards for 
the electronic exchange of health care data; to specify what 
medical and administrative code sets should be used within 
those standards; to require the use of national identification 
systems for health care patients, providers, payers (or plans), 
and employers (or sponsors); and to specify the types of 
measures required to protect the security and privacy of  
personally identifiable health care information.2 
 
2Centers for Medicaid & Medicare Services. HIPAA Administrative Simplification    
Glossary. Retrieved March 9, 2005, from http://www.cms.hhs.gov/glossary/default.
asp?Letter=ALL&Audience=7 
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Glossary 
 
Authorization Elements: Information that must be  
included in a written authorization of PHI. These elements are:  
a specific and meaningful description of the elements of PHI 
to be disclosed, the names or other specific identification 
about the person, persons, or class of persons (e.g.  
“researcher’s staff”) authorized to make the request for use or 
disclosure, the names or other specific identification of the 
persons to whom the covered entity may make the requested 
use or disclosure, a description of the purpose of the  
requested use or disclosure, an authorization expiration date 
or event (for research purposes “none” or “the end of the  
research project” are acceptable), signature of the individual 
or his/her legally authorized representative (with a description 
of the representative’s authority, e.g. “John Smith, Power of  
Attorney for Jane Doe”), and the date. It also must include a 
statement that the participant has the right to revoke  
authorization at any time, an indication whether treatment or  
enrollment in services, or benefits is dependent on  
authorization, the consequences of refusing to sign the  
authorization, and a statement that the PHI may be  
re-disclosed by the recipient. (For example, a researcher 
might disclose PHI to a sponsor or funding agency. If the  
funding agency was a not a business associate of the  
research organization, nor a covered entity, the Privacy Rule 
would no longer apply although they would still be required to 
maintain confidentiality responsibilities under other laws.) 
 
Business Associate: A person who performs or  
assists in the performance of a function or activity involving 
the use or disclosure of individually identifiable health  
information such as claims processing or data analysis. A per-
son employed by a covered entity is not a business associate 
of that entity. 
 
           Covered Entity: A health plan, health care  
clearinghouse, or health care provider, and in some cases  
researchers, who use electronic transmission of health  
information in connection with a transaction in accordance 
with Health and Human Services’ standards. 
13 
• Office of the Assistant Secretary for Planning and 
Evaluation U.S. Department of Health and Human  
Services 
http://aspe.hhs.gov/admnsimp/final/pvcguide1.htm 
 
• Office for Human Research Protections (OHRP), HHS 
http://www.hhs.gov/ohrp 
 
• State of Ohio.  HIPAA Ohio.  
     http://www.hipaa.ohio.gov/  
 
• Substance Abuse and Mental Health Services Admini-
stration (SAMHSA) 
http://www.hipaa.samhsa.gov/ 
 
• University of Minnesota 
http://www.irb.umn.edu/guidance/hipaa/faqhipaa. 
cfm#waiver 
 
                                                         ÚÚÚ 
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Introduction to HIPAA 
           
The Health Insurance Portability and Accountabil-
ity Act of 1996 (HIPAA)* was primarily designed to protect 
health insurance coverage for workers and their families 
upon a worker’s change in or loss of employment. Besides 
insurance portability HIPAA has changed the way health care 
providers share and use protected health information (PHI) 
by establishing strict federal standards both for electronic 
data interchange (EDI) and for protecting patients’  
confidentiality.           
The HIPAA Privacy Rule, effective in April 2003, is the 
first of three major changes that affect the entire health care 
delivery system as a result of 
Title II of HIPAA—
Administrative Simplification. 
The second major change  
occurred in October 2003 
when new rules governing the 
electronic exchange of data 
between providers and health 
plans went into effect. A final 
HIPAA provision regarding 
the security of data was  
effective in April 2005. 
          PHI includes 18 types 
of information such as  
patients’ names, addresses, 
identification numbers—even 
their zip codes or license 
plate numbers. Health care  
consumers are notified of 
their rights to privacy every 
time  they visit a new  
physician, dentist, or  
pharmacy.  HIPAA was 
  
*Boldfaced terms are included in a  
glossary at the end of this document. 
Definition-
Protected Health 
Information (PHI): This is 
individually identifiable health 
information that is 
transmitted by electronic 
media, maintained in 
electronic media, or shared 
in any other form or medium.
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designed to protect the confidentiality of health care  
recipients and to prevent unauthorized access to and use of 
health care information. In addition to changes in the way 
our dentists, physicians, and pharmacists do business,  
HIPAA has also changed the relationship between long-term 
care service providers, their clients, and researchers. The 
scope of activity to which the HIPAA privacy rule applies is 
often viewed too narrowly. HIPAA applies to other types of 
providers and intermediaries besides doctors, hospitals, and 
health insurance carriers. Nursing homes and home care 
agencies are subject to HIPAA regulations as well. For  
example, the state of Ohio has determined that HIPAA  
applies to all its Medicaid home and community-based 
waiver programs such as PASSPORT. 
Long-term care service providers often are  
approached by researchers for access to their clients or  
residents to participate in a variety of research studies. A 
group of gerontology students may want to interview  
residents about their lives during World War II, a faculty  
researcher may want to recruit caregivers for a study on 
time-use among families who receive home and  
community-based  
services, or a medical 
school researcher may 
want to test a gait-
training program with 
older people prone to 
falls. Long-term care  
clients often provide a 
ready pool of  
participants who share 
some quality that is  
important to research. 
Long-term care  
providers (covered  
entities) often invite  
researchers into their facilities or organizations to help them 
improve their services or to evaluate a new program or  
intervention.   
 Definition-
A covered entity is an 
organization that transmits 
health care information 
electronically for a variety of 
purposes such as payment.  
Although they may share 
health care information 
through a variety of other 
means – orally, or on paper, 
they are subject to HIPAA 
regulations. 
2 
Additional Resources 
 
HIPAA Privacy Rule 
• The final HIPAA Privacy Rule is available at  
http://www.hhs.gov/ocr/hipaa 45 Code of Federal  
Regulations, Part 160 and Subparts A and E of Part 164. 
 
Agencies 
• Office for Civil Rights (OCR), Department of Health and 
Human Services (HHS) http://www.hhs.gov/ocr/hipaa 
 
• Agency for Healthcare Research and Quality (AHRQ) 
http://www.ahcpr.gov/ 
 
• Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/nip/registry/hipaa7.htm 
 
• Food and Drug Administration (FDA) 
http://www.fda.gov/ 
 
• Indian Health Services (IHS) 
http://www.ihs.gov/AdminMngrResources/HIPAA/index.cfm 
 
• Mental Health in Ohio HIPAA Website 
http://www.mh.state.oh.us/hipaa/hipaa.index.html 
 
• National Institutes of Health (NIH) 
http://privacyruleandresearch.nih.gov/ 
 
• North Carolina Healthcare Information and Communication 
Alliance, Inc. (NCHICA) 
http://nchica.org/ 
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agreement, it has violated the Privacy Rule. If a 
covered entity knows a recipient with a data use 
agreement has violated the agreement the covered 
entity must take steps to correct the activity or  
practice. If these steps are not successful, the  
covered entity must discontinue disclosure of PHI 
to the recipient and notify the Department of Health 
and Human Services. 
 
This summary provides a brief look at HIPAA and its 
implications for research in long-term care. The information 
in this brochure is designed to educate and promote  
discussion and should not be construed as legal advice.  
Final decisions as to the appropriate strategies to be  
followed for researchers should be made by Institutional 
Review Boards and, where necessary, with advice from 
appropriate legal counsel. 
 
                                                        ÚÚÚ 
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           Long-term care providers may allow researchers to 
interview their residents as part of an evaluation of long-
term care services, or they may allow gerontology students 
to interview residents as part of a research methods class.   
           The problem today is how to ensure that important  
research regarding long-term care service provision  
continues, while protecting long-term care providers and  
clients. The questions below are designed to address the  
HIPAA issues relevant to researchers in long-term care. 
 
ÚÚÚ 
 
Who is affected by the HIPAA statute and 
implementing regulations? 
 
Any health care plan, health care clearinghouse, or 
health care provider that transmits individually identifiable 
health care information electronically is a covered entity 
and is required to comply with HIPAA. A long-term care  
facility that transmits data to the state Medicaid office  
electronically is a covered entity. A service provider that 
submits claims to Medicaid is a covered entity. 
Researchers might also be considered covered entities if 
they are employed by a university that has a hospital —
unless the hospital is designated as a separate unit within 
the university, and the researchers are not employed in that 
separate unit. In that case, only the hospital and its  
workforce would be covered entities. However,  
researchers who receive health care information from  
covered entities have certain obligations under HIPAA. 
Covered entities may enter into business associate 
agreements with other individuals or organizations to  
provide services using PHI on their behalf. For example, 
business associates might provide accounting services 
based on PHI. 
 
                                       ÚÚÚ 
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What kind of information is covered by  
HIPAA? 
 
Any information collected by a covered entity that  
relates to the past, present, or future physical or mental 
health condition of an individual; the health care provided to 
an individual; or the past, present, or future payment for the  
provision of health care to an individual is Protected Health  
Information (PHI) and therefore subject to the HIPAA rule.  
Information also covered under PHI includes demographic 
items such as name, address, and social security number 
that would allow the identification of an individual (see the 
glossary for a complete list). The information does not have 
to be collected or transmitted electronically—information  
transmitted orally, on paper, or electronically, is protected 
health information.  
 
                                ÚÚÚ 
 
What does HIPAA have to do with research? 
 
According to HIPAA, research is subject to regulation.    
“Research” is defined by federal law as: “a systematic  
investigation, including research development, 
testing, and evaluation, designed to develop 
or contribute to generalizable knowledge”  
(45 CFR 164.501). HIPAA covers ONLY  
research that includes health care information 
as one of its components. HIPAA does not  
replace other federal or state guidelines  
governing human subjects in research; it supplants those 
regulations with specific guidelines concerning the privacy of 
information obtained or created in the course of conducting 
research. 
Covered entities can still conduct their own quality  
assessments and outcomes and evaluation research outside 
the HIPAA regulations as long as they are not attempting to 
create generalizable knowledge. If, however, they see their  
4 
set with a research organization. A limited data set  
excludes specified direct identifiers of the individual or of 
their relatives, employers, or household members. 
 
A data use agreement must: 
 
1.  Establish the permitted uses and disclosures of the 
limited data set by the recipient, consistent with the 
purposes of the research. Use may not include any 
disclosure that would violate the Privacy Rule if done 
by a covered entity; 
 
2.  Limit who can use or receive the data; and 
 
3.  Require the recipient to agree to:  
 
a.  Limit its use or disclosure of the information to the 
                use permitted by the data use agreement or as 
otherwise required by law; 
 
b. Use appropriate safeguards to prevent the use or 
disclosure of the information other than as  
provided for in the data use agreement; 
 
c. Report to the covered entity any use or  
disclosure of the information not provided for by 
the data use agreement of which the recipient 
becomes aware; 
 
d. Ensure that any agents (including subcontractors, 
to whom the recipient provides the limited data 
set) agree to the same restrictions and conditions 
that apply to the recipient with respect to the  
limited data set; and 
 
4.  Not re-identify the information or contact the study  
individuals. If a covered entity is the recipient of a 
limited data set and violates the data use  
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covered entity (service provider) with the approval it needs 
to release names and addresses to a researcher for  
research subject recruitment. Also, if researchers carefully 
monitor the safety of the PHI while conducting their  
research and maintain the PHI no longer than necessary, 
and the PHI elements are necessary to reasonably conduct 
the research, the criteria for IRB approval of a waiver or  
alteration of authorization have been met.   
                                 
        ÚÚÚ 
 
Using de-identified data. 
 
De-identified PHI contains no individual  
identifiers; the identifying data are stripped or removed from 
a data set by a covered entity before the data are provided 
to researchers. The Privacy Rule allows a covered entity 
to de-identify data by removing all PHI elements that could 
be used to identify the individual or the individual’s relatives, 
employers, or household members. The covered entity 
also must have no actual knowledge that the remaining  
information could be used alone or in combination with 
other information to identify the individual who is the subject 
of the information. 
De-identified information is not subject to the  
HIPAA Privacy Rule.  
 
                            ÚÚÚ 
 
Obtaining a limited data set and data use  
agreement. 
 
A limited data set can be used for purposes of  
research, public health, or health care operations without 
the researcher obtaining an individual’s authorization for its 
use or disclosure as long as a data use agreement is in 
place. 
The HIPAA Privacy Rule allows a covered entity to    
enter into a data use agreement for sharing a limited data  
 8 
knowledge base as having usefulness outside their organiza-
tion, they are likely to be seen as conducting research,  
particularly if they publish or present their findings to people  
outside their organization. 
When researchers recruit research participants through 
service providers, identifying residents by name implicitly  
divulges that a person of that name is receiving a particular 
type of long-term care service or even is associated with a  
certain diagnosis. Any information about the services  
someone is receiving is protected health information. There 
are strategies, however, that will allow researchers to recruit 
clients through service providers and to conduct research in 
long-term care settings. 
 
  ÚÚÚ 
 
How can long-term care research be  
conducted? 
 
There are a number of strategies that can be followed 
to conduct HIPAA compliant research on long-term care  
services and clients. These are: obtaining authorization from  
individuals to release PHI,  
obtaining a waiver of  
authorization from the research  
organization’s Institutional  
Review Board (IRB), using  
de-identified data, or using a 
limited data set. As with many 
research choices, there are  
advantages and disadvantages 
to each of these; the strategy 
chosen depends upon the  
research question, the  
population being studied, and the level of time and effort that 
the researcher can devote to obtaining health information. 
  
 ÚÚÚ  
 
Definition-
Institutional Review 
Board (IRB): An IRB is a 
board or other group 
designated by an 
institution to review the 
legal and ethical aspects 
of research involving 
humans as subjects. 
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Obtaining authorization from individuals to  
release PHI. 
 
The most straightforward strategy for release of health 
information is to obtain written authorization from individuals 
who are being recruited as research participants. A service 
provider could recruit research participants and release the 
names of only those who authorize such a release. They 
might do this by mailing the researcher’s recruitment letter to 
a group of potential participants. Unfortunately, this is extra  
effort for service providers and does not allow the researcher 
to address any questions the clients might have about the 
study before giving permission. These strategies often result 
in a lower participation rate than would have been obtained if 
the researcher approached clients directly. 
Written authorization from research participants can 
be obtained as part of the signed consent form usually  
required in human subjects research, as long as all of the  
authorization elements are included in the consent form. In 
general, these elements outline the purpose of the  
disclosure, the persons to whom, and the conditions under 
which, PHI will be disclosed. 
                                      
                                            ÚÚÚ 
 
Obtaining a waiver of authorization. 
 
           There are situations in which obtaining written  
authorization from participants for release of PHI is not  
practical or possible. This is likely to be true when data are 
centrally gathered about clients who are geographically  
dispersed, or who will only be contacted by telephone. In 
these cases an Institutional Review Board (IRB) can grant 
a full or partial waiver of authorization. According to the  
National Institutes of Health, “A complete waiver occurs when 
an IRB determines that a covered entity does not need  
authorization for all PHI uses and disclosures for research 
purposes, such as disclosing PHI for research recruitment  
6 
purposes. An IRB may  also approve a request that removes 
some PHI but not all, or alters the requirements for an  
authorization.” Thus, a researcher’s university IRB or a  
covered entity’s Privacy Board can grant a waiver or  
alteration of authorization, provided that the waiver request 
satisfies the following criteria: 
 
1)  The use or disclosure of the PHI involves no more 
than minimal risk, based on the presence of the 
following elements: 
 
a. An adequate plan to protect identifiers from  
     improper use and disclosure; 
 
b.  An adequate plan to destroy identifiers at the 
earliest opportunity (where there is not a  
research or legal justification for retaining 
them); 
 
c. Adequate written assurances that the PHI will 
not be reused or shared with any other person 
or entity, except as required by law for  
oversight of the study, or for other research for 
which the use or disclosure of the PHI would 
be permitted under the Privacy Rule; 
 
2)  The research could not feasibly be conducted 
without the waiver or alteration; and 
 
3)  The research could not feasibly be conducted 
without access to and use of the PHI.1 
 
           This language suggests that an IRB can approve the 
use of PHI for research subject recruitment. For example, a  
university researcher’s IRB approval can provide the  
 
 
 
1NIH, August 2003, Institutional Review Boards and the HIPAA Privacy Rule,  
NIH Pub. No. 03-5428. 
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